Skip to content
Research Article Open access CC BY 4.0

An In-silico Pharmacokinetics Study on Cis-Heptadeca-1,9-Diene-4,6-Diyne-3,8-Diol: A Nutraceutical Compound with Anticancer Properties

Paul Tobechukwu Okoli, Vivian Chiadikaobi Nzute, Olanrewaju Ayodeji Durojaye, Ogechukwu Henrietta Chielo, Queensley Chinyere Ajibo, Solomon Imaga Udo, Sandra Munachiso Ezeh

Asian Food Science Journal · pp. 1–7 · Published 9 Mar 2019

10.9734/afsj/2019/v7i329972

Abstract

The polyacetylenic compound cis-heptadeca-1,9-diene-4,6-diyne-3,8-diol with the trivial name of falcarindiol, has been shown through various studies to exhibit anticancer activities. The beneficial effects of polyacetylenes occur at nontoxic concentrations and thus represent pharmacologically useful properties indicating that polyacetylenes may be important nutraceuticals of vegetables. In the human diet, carrots are the major dietary source of falcarinol-type polyacetylenes, in particular falcarinol and falcarindiol. The prediction of physicochemical parameters relevant for drug likeness was performed by computational methods. The Lipinski, Ghose and Veber rules were applied to assess drug likeness and to predict whether the compound is likely to be a bioactive compound according to other important parameters such as molecular weight, LogP, number of hydrogen bond donors and hydrogen bond acceptors. The SwissADME tool used vector machine algorithm (SVM) with fastidiously cleaned large datasets of known inhibitors/non-inhibitors as well as substrates/non-substrates for its predictions. Results from the in silico pharmacokinetics study on falcarindiol showed that the compound exhibited drug likeness characteristics and as such can serve the purpose of an anticancer agent, being a nutaceutical and bioactive component of falcarindiol.

Falcarindiol polyacetylenes lipinski ghose pharmacokinetics

Cited by 11

De novo design and evaluation of dual inhibitory peptide binders targeting MDMX-p53 and MDM2-p53 interactions

Olanrewaju Ayodeji Durojaye, Sm Faysal Bellah, H. Uzoeto · Beni-Suef University Journal of Basic and Applied Sciences · 2026

Harnessing AI-driven reverse docking in drug discovery: a comprehensive review of opportunities, challenges, and emerging trends

Olanrewaju Ayodeji Durojaye, Sm Faysal Bellah, H. Uzoeto · Journal of Molecular Modeling · 2025

Computational biology meets oncology: designing custom protein and peptide binders to outsmart cancer.

Olanrewaju Ayodeji Durojaye, H. Uzoeto, N. O. Okoro · Medical Oncology · 2025

CSC01 shows promise as a potential inhibitor of the oncogenic G13D mutant of KRAS: an in silico approach

Olanrewaju Ayodeji Durojaye, Umer Ejaz, H. Uzoeto · Amino Acids · 2023

In Silico Identification of the Potential Natural Inhibitors of SARS-CoV-2 Guanine-N7 Methyltransferase.

A. Rowaiye, O. Onuh, J. Oladimeji-Salami · RESEARCH RESULTS IN BIOMEDICINE · 2020

ELECTRONIC, STRUCTURAL AND PHARMACOCINETIC CHARACTERIZATION OF TRICYCLIC ALKALOID ALTERNAMIDE A: A SEMI-EMPIRICAL QUANTUM STUDY AND ADMET

S. Estácio, Francisco Rogênio da Silva Mendes, E. M. Marinho · International journal of research - granthaalayah · 2020

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

11

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.